ViroGates A/S

Copenhagen Stock Exchange VIRO.CO

ViroGates A/S Price to Sales Ratio (P/S) on January 14, 2025: 14.42

ViroGates A/S Price to Sales Ratio (P/S) is 14.42 on January 14, 2025, a 57.85% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

ViroGates A/S 52-week high Price to Sales Ratio (P/S) is 23.43 on November 12, 2024, which is 62.51% above the current Price to Sales Ratio (P/S).
ViroGates A/S 52-week low Price to Sales Ratio (P/S) is 5.83 on April 18, 2024, which is -59.55% below the current Price to Sales Ratio (P/S).
ViroGates A/S average Price to Sales Ratio (P/S) for the last 52 weeks is 8.67.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Copenhagen Stock Exchange: VIRO.CO

ViroGates A/S

CEO	Mr. Jakob Knudsen
IPO Date	June 26, 2018
Location	Denmark
Headquarters	BanevAenget 13
Employees	10
Sector	Health Care
Industries Pharmaceuticals Biotechnology Clinical Trials Medical Instruments

Description

ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and suPARnostic ELISA that provides fully quantitative results. Its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was incorporated in 2000 and is headquartered in Birkerød, Denmark.

Key trends

Past 5 years